News Focus
News Focus
icon url

learningcurve2020

05/04/21 10:24 AM

#374400 RE: Dr Bala #374397

Why should investors need to wait to know if trial survivors lives may have been positively influenced by other therapies these last four years? Isn't that beyond the scope of being blinded and material to making an investment decision?